UC Riverside Scientists Use AI to Drive COVID Countermeasure Discovery Medical Countermeasures August 12, 2020 …
NIAID-Led Study of COVID-19 mRNA Vaccine Supports Advance to Phase 3 Human Trials Medical Countermeasures July 28, 2020 …
Moderna’s COVID-19 Vaccine Generally Well Tolerated in Ongoing Phase 1 Trial Medical Countermeasures July 14, 2020 …
Many Flu Strains May Be Capable of Mutating to Escape Universal-Vaccine Antibodies Medical Countermeasures June 24, 2020 …
Funding for Preclinical Development of Countermeasures Against Select Pathogens Contracts + Grants June 8, 2020 …
Promising Results from Phase 1 Trial of Equine Encephalitis Virus Vaccine Medical Countermeasures June 8, 2020 …
AstraZeneca Teams with Oxford Biomedica to Shore Up COVID-19 Vaccine Manufacturing Capacity Industry News May 28, 2020 …
GSK Announces Plans to Produce 1 Billion Doses of Pandemic Vaccine Adjuvant in 2021 Industry News May 28, 2020 …
First Human Trial of COVID-19 Vaccine Finds it is Safe and Induces Rapid Immune Response Medical Countermeasures May 22, 2020 …
The Challenges of Developing a Safe and Effective COVID-19 Vaccine Medical Countermeasures May 12, 2020 …
Inactivated Vaccine Candidate Protects Macaques From SARS-Cov-2 Infection Medical Countermeasures May 6, 2020 …
NYU Langone Health Enrolling Patients in US Clinical Trial For COVID-19 mRNA Vaccine Medical Countermeasures May 5, 2020 …
Emergex and GMU’s National Center for Biodefense and Infectious Diseases Partner for Highly Pathogenic RNA Virus Studies Industry News April 22, 2020 …
Researchers Develop New Microneedle Array Combination Vaccine Delivery System Medical Countermeasures April 21, 2020 …
Investigational Chimp Adenovirus MERS-CoV Vaccine Protects Monkeys Medical Countermeasures April 17, 2020 …
New Universal Ebola Vaccine May Fight All Four Virus Species that Infect Humans Medical Countermeasures April 16, 2020 …
